
WHO approves trials for two new Ebola vaccines
The story in brief
The World Health Organization approved clinical trials for two new Ebola vaccines designed to combat the Bundibugyo strain, which has caused over 5,300 deaths in the DRC. The DRC’s National Institute for Biomedical Research is leading the trials, with results expected in early 2027. A British healthcare worker infected with Ebola is being evacuated to the UK, though the risk to the public remains low.